Show simple item record

dc.contributor.authorCyril, Asha Caroline
dc.date.accessioned2022-01-19T04:42:02Z
dc.date.available2022-01-19T04:42:02Z
dc.date.issued2021
dc.identifier.other204-2021.34
dc.identifier.urihttps://repository.mbru.ac.ae/handle/1/739
dc.description.abstractAbstract: Over the last two decades, several advancements have been made to improve the therapeutic efficacy of plant flavonoids, especially in cancer treatment. Factors such as low bioavailability, poor flavonoid stability and solubility, ineffective targeted delivery, and chemo-resistance hinder the application of flavonoids in anti-cancer therapy. Many anti-cancer compounds failed in the clinical trials because of unexpected altered clearance of flavonoids, poor absorption after administration, low efficacy, and/or adverse effects. Hence, the current research strategies are focused on improving the therapeutic efficacy of plant flavonoids, especially by enhancing their bioavailability through combination therapy, engineering gut microbiota, regulating flavonoids interaction with adenosine triphosphate binding cassette efflux transporters, and efficient delivery using nanocrystal and encapsulation technologies. This review aims to discuss different methodologies with examples from reported dietary flavonoids that showed an enhanced anti-cancer efficacy in both in vitro and in vivo models. Further, the review discusses the recent progress in biochemical modifications of flavonoids to improve bioavailability, solubility, and therapeutic efficacy.en_US
dc.language.isoenen_US
dc.subjectFlavonoidsen_US
dc.subjectBioavailabilityen_US
dc.subjectGut microbiotaen_US
dc.subjectNanotechnologyen_US
dc.subjectCancer treatmenten_US
dc.titleCurrent methodologies to refine bioavailability, delivery, and therapeutic efficacy of plant flavonoids in cancer treatmenten_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record